Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine Succinylation
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Lysine succinylation, a protein modification, impacts cancer by altering cell metabolism, gene expression, and immune response. Targeting this process shows promise for future cancer treatments.
Area Of Science
- Biochemistry
- Molecular Biology
- Oncology
Background
- Lysine succinylation is an emerging post-translational protein modification.
- It influences protein structure, activity, and function, and is implicated in various diseases.
- This modification occurs via enzymatic and non-enzymatic pathways.
Purpose Of The Study
- To provide an overview of the biological functions of lysine succinylation in cancer.
- To explore the potential applications of lysine succinylation in cancer treatment.
- To offer a novel perspective for future cancer management.
Main Methods
- Literature review of studies on lysine succinylation in cancer biology.
- Analysis of the role of lysine succinylation in metabolic reprogramming, gene expression, and oncogenic signaling.
- Examination of lysine succinylation's impact on immune cell activity and tumor immune evasion.
Main Results
- Lysine succinylation significantly influences tumor cell metabolic reprogramming, gene expression, and oncogenic signaling pathways.
- It modulates immune cell activity, affecting tumor immune evasion.
- Inhibitors and activators of lysine succinylation are being developed to target cancer progression.
Conclusions
- Lysine succinylation plays a critical role in various aspects of cancer biology.
- Targeting lysine succinylation presents a promising strategy for novel cancer therapies.
- Further research into lysine succinylation could lead to significant advancements in cancer management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...